ctrl K

Watchlist Price Alert

Janux Therapeutics Inc. (JANX)

NASDAQ: JANX · Real-Time Price · USD

23.57

0.95 (4.20%)

At close: May 15, 2025, 2:05 PM

Janux Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	10.59M	8.08M	8.61M	3.64M	n/a	n/a
Cost of Revenue	n/a	1.96M	841K	113K	13K	6K
Gross Profit	8.53M	6.13M	7.77M	3.52M	-13K	-6K
Operating Income	-98.85M	-72.98M	-67.09M	-32.93M	-4.84M	-3.77M
Interest Income	29.85M	14.69M	4.03M	257K	206K	233K
Pretax Income	-68.99M	-58.29M	-63.06M	-32.67M	-6.78M	-4M
Net Income	-68.99M	-58.29M	-54.15M	-32.56M	-5.25M	-4.24M
Selling & General & Admin	41.05M	26.14M	22.26M	10.33M	1.8M	772K
Research & Development	68.39M	54.92M	53.44M	26.24M	3.04M	3M
Other Expenses	n/a	n/a	4.03M	257K	-1.74M	n/a
Operating Expenses	109.44M	81.06M	75.7M	36.57M	4.84M	3.77M
Interest Expense	n/a	n/a	4.03M	n/a	206K	233K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	109.44M	81.06M	75.7M	36.57M	4.84M	3.77M
Income Tax Expense	n/a	n/a	-8.9M	-113K	-1.53M	233K
Shares Outstanding (Basic)	53.75M	44.02M	41.47M	41.24M	41.61M	41.61M
Shares Outstanding (Diluted)	53.75M	44.02M	41.47M	41.24M	41.61M	41.61M
EPS (Basic)	-1.28	-1.32	-1.31	-0.79	-0.13	-0.1
EPS (Diluted)	-1.28	-1.32	-1.31	-0.79	-0.13	-0.1
EBITDA	-98.85M	-71.02M	-66.25M	-32.82M	-4.83M	-3.77M
EBIT	-98.85M	-72.98M	-67.09M	-32.93M	-6.58M	-3.77M
Depreciation & Amortization	n/a	1.96M	841K	113K	13K	6K